Living donor pancreas transplantation

Rainer W G Gruessner, David E R Sutherland

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The pancreas was the first extrarenal organ to be successfully transplanted with use of a living donor. The goal at that time, in the azathioprine and cyclosporine eras, was to improve graft survival rates after solitary pancreas transplants. But today, in the tacrolimus era, most living donor pancreas transplants are with a simultaneous living donor kidney transplant because of the cadaver kidney donor shortage. The evolution of stringent selection criteria for living pancreas donors has significantly reduced the incidence of surgical complications and adverse metabolic changes. In contrast to kidney and liver transplants with use of living donors, the donor mortality rate after more than 140 living donor pancreas transplants has remained 0%, The introduction of laparoscopic donor hernipancreatectomy, with its rapid recovery time, makes living pancreas donation more attractive. Patient and graft survival rates for living donor pancreas recipients are now greater than 85%. Living donor pancreas (with or without a simultaneous living donor kidney) transplants decrease the number of deaths of diabetic patients on dialysis and on the waiting list, help overcome the organ shortage, reduce morbidity, and improve the quality of life for patients formerly on dialysis or with debilitating side effects of diabetes. Meticulous donor workup remains key to a low metabolic and surgical complication rate.

Original languageEnglish (US)
Pages (from-to)108-119
Number of pages12
JournalTransplantation Reviews
Volume16
Issue number2
StatePublished - 2002
Externally publishedYes

Fingerprint

Pancreas Transplantation
Living Donors
Pancreas
Transplants
Tissue Donors
Kidney
Graft Survival
Dialysis
Survival Rate
Waiting Lists
Azathioprine
Tacrolimus
Cadaver
Patient Selection
Cyclosporine
Quality of Life
Morbidity
Mortality

ASJC Scopus subject areas

  • Transplantation

Cite this

Gruessner, R. W. G., & Sutherland, D. E. R. (2002). Living donor pancreas transplantation. Transplantation Reviews, 16(2), 108-119.

Living donor pancreas transplantation. / Gruessner, Rainer W G; Sutherland, David E R.

In: Transplantation Reviews, Vol. 16, No. 2, 2002, p. 108-119.

Research output: Contribution to journalArticle

Gruessner, RWG & Sutherland, DER 2002, 'Living donor pancreas transplantation', Transplantation Reviews, vol. 16, no. 2, pp. 108-119.
Gruessner, Rainer W G ; Sutherland, David E R. / Living donor pancreas transplantation. In: Transplantation Reviews. 2002 ; Vol. 16, No. 2. pp. 108-119.
@article{61b15609106a40b082a36de579c83f02,
title = "Living donor pancreas transplantation",
abstract = "The pancreas was the first extrarenal organ to be successfully transplanted with use of a living donor. The goal at that time, in the azathioprine and cyclosporine eras, was to improve graft survival rates after solitary pancreas transplants. But today, in the tacrolimus era, most living donor pancreas transplants are with a simultaneous living donor kidney transplant because of the cadaver kidney donor shortage. The evolution of stringent selection criteria for living pancreas donors has significantly reduced the incidence of surgical complications and adverse metabolic changes. In contrast to kidney and liver transplants with use of living donors, the donor mortality rate after more than 140 living donor pancreas transplants has remained 0{\%}, The introduction of laparoscopic donor hernipancreatectomy, with its rapid recovery time, makes living pancreas donation more attractive. Patient and graft survival rates for living donor pancreas recipients are now greater than 85{\%}. Living donor pancreas (with or without a simultaneous living donor kidney) transplants decrease the number of deaths of diabetic patients on dialysis and on the waiting list, help overcome the organ shortage, reduce morbidity, and improve the quality of life for patients formerly on dialysis or with debilitating side effects of diabetes. Meticulous donor workup remains key to a low metabolic and surgical complication rate.",
author = "Gruessner, {Rainer W G} and Sutherland, {David E R}",
year = "2002",
language = "English (US)",
volume = "16",
pages = "108--119",
journal = "Transplantation Reviews",
issn = "0955-470X",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Living donor pancreas transplantation

AU - Gruessner, Rainer W G

AU - Sutherland, David E R

PY - 2002

Y1 - 2002

N2 - The pancreas was the first extrarenal organ to be successfully transplanted with use of a living donor. The goal at that time, in the azathioprine and cyclosporine eras, was to improve graft survival rates after solitary pancreas transplants. But today, in the tacrolimus era, most living donor pancreas transplants are with a simultaneous living donor kidney transplant because of the cadaver kidney donor shortage. The evolution of stringent selection criteria for living pancreas donors has significantly reduced the incidence of surgical complications and adverse metabolic changes. In contrast to kidney and liver transplants with use of living donors, the donor mortality rate after more than 140 living donor pancreas transplants has remained 0%, The introduction of laparoscopic donor hernipancreatectomy, with its rapid recovery time, makes living pancreas donation more attractive. Patient and graft survival rates for living donor pancreas recipients are now greater than 85%. Living donor pancreas (with or without a simultaneous living donor kidney) transplants decrease the number of deaths of diabetic patients on dialysis and on the waiting list, help overcome the organ shortage, reduce morbidity, and improve the quality of life for patients formerly on dialysis or with debilitating side effects of diabetes. Meticulous donor workup remains key to a low metabolic and surgical complication rate.

AB - The pancreas was the first extrarenal organ to be successfully transplanted with use of a living donor. The goal at that time, in the azathioprine and cyclosporine eras, was to improve graft survival rates after solitary pancreas transplants. But today, in the tacrolimus era, most living donor pancreas transplants are with a simultaneous living donor kidney transplant because of the cadaver kidney donor shortage. The evolution of stringent selection criteria for living pancreas donors has significantly reduced the incidence of surgical complications and adverse metabolic changes. In contrast to kidney and liver transplants with use of living donors, the donor mortality rate after more than 140 living donor pancreas transplants has remained 0%, The introduction of laparoscopic donor hernipancreatectomy, with its rapid recovery time, makes living pancreas donation more attractive. Patient and graft survival rates for living donor pancreas recipients are now greater than 85%. Living donor pancreas (with or without a simultaneous living donor kidney) transplants decrease the number of deaths of diabetic patients on dialysis and on the waiting list, help overcome the organ shortage, reduce morbidity, and improve the quality of life for patients formerly on dialysis or with debilitating side effects of diabetes. Meticulous donor workup remains key to a low metabolic and surgical complication rate.

UR - http://www.scopus.com/inward/record.url?scp=0036328733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036328733&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036328733

VL - 16

SP - 108

EP - 119

JO - Transplantation Reviews

JF - Transplantation Reviews

SN - 0955-470X

IS - 2

ER -